Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Mol Oral Microbiol. 2010 Nov 18;26(1):2–18. doi: 10.1111/j.2041-1014.2010.00581.x

Table 1.

Bacterial strains, plasmids and primers used in this study

Strains/plasmid Relevant characteristics References
S. mutansUA159 Wild-type (Ajdic et al., 2002)
S. mutans TW26D ΔluxS, Kanr This study
S. mutans TW297.1 Δsmu.44, Kanr This study
S. mutans TW238 Δsmu.423, Kanr This study
S. mutans TW294.1 Δsmu.46, Kanr This study
S. mutans TW310 Δsmu.299, Kanr This study
pDL278 Shuttle vector, Spr (LeBanc & Lee, 1991)
pDL278:luxS Shuttle carrying luxS, Spr This study
S. mutans TW26DC TW26D/pDL278:luxS, Ermr and Spr This study
pAYBG754S Shuttle vector with a gfp reporter, Kanr (Yoshida & Kuramitsu, 2002)
Primers for mutagenesis Sequence (5′–3′) Sequence (5′–3′) Flanking region amplified
luxS 5F 55-aaatctgtcattgctgatggac 53-atacccgagctcctactgagtagtc 5′ of luxS for mutagenesis
luxS 3F 35-agttcaaagctttcaacagtaacttc 33-tgctagacgttgcatagcttgagc 3′ of luxS for mutagenesis
smu.44 5F 55-tgttggaaatccaccatatattacgtatc 53-tgcacttctgaattctagtacattc 5′ of smu.44 for mutagenesis
smu.44 3F 35-ttcataacaggagaattcttagatac 33-tccttcttcactaaagtgttgtac 3′ of smu.44 for mutagenesis
smu.46 5F 55-agatagtcttgttaacaaacatc 53-agtttgccagaattcaatagcatc 5′ of smu.46 for mutagenesis
smu.46 3F 35-tagaacaccagaattctattaatcaac 33-acgaccaccagaaccaacaac 3′ of smu.46 for mutagenesis
smu.423 5F 55-tcactattactgatgtccaaatg 53-ttgttcaaatgcatgcgtattcat 5′ of smu.423 for mutagenesis
smu.423 3F 35-tgtaggtgcatgcactttttgttg 33-ttcttcactcattttgatgtc 3′ of smu.423 for mutagenesis
smu.299 5F 55-atgattcatctcgatcaagcc 53-tacatgtgaattcgtttcagcatc 5′ of smu.299 for mutagenesis
smu.299 3F 35-tagtaaatagctggaattcaggtgc 33-tgaaaccagatcagctgttgac 3′ of smu.299 for mutagenesis

Primers for qPCR Forward (5′–3′) Reverse (5′–3′) Application

16S-1 rRNA cacaccgcccgtcacacc cagccgcaccttccgatacg 16S rRNA fragment, 160 bp
smu.1128 aagggtgggttcggacttgg gcaggcgagcttcaaacattac ciaH fragment, 115 bp
smu.1528 cggatgcgtgttgctcttactg ggctgataaccaacggctgatg atpD fragment, 164 bp
smu.1877 ggtccttcacttggcata ctgccattggtaagttcatccc mannose-PST, EIIDMan, 79 bp
smu.1961 ggaagccctttgacaacagc gcattcatcaatctggttctat levD fragment, 94 bp
smu.299 acgatggagctaatggctatgc agcgtaagcggcaaaacttg smu.299 fragment, 140 bp
smu.423 ggtggtggtatgattagatgtgc ccagaccagcctcctaaagc smu.423 fragment, 137 bp
smu.43 agcaaccagttatcttagg gtataatatagaatcccgaatagg smu.43 fragment, 200 bp
smu.44 tggcagactgggaaatataagc ggcaaactcactcattgacaac smu.44 fragment, 148 bp
smu.45 gttacaggataccacggctgaag accttgagttgccatagttcgtag Smu.45 fragment, 96 bp
smu.46 cacatagtgatgatgtccaaattg gcatcagacttctttaaacttg smu.46 fragment, 199 bp
smu.47 ctgccacatagacgagaa gtttacaattccacccacaa smu.47 fragment, 124 bp
smu.610 ttgccgatgaaacgaccactac tcagcttccttactcgcactcc spaP fragment, 115 bp
smu.78 gggacttgggaagtacgagaag aaacaagagctgctgcaccg fruA fragment, 148 bp
smu.872 gcggcttatgttacgggtacg aaagcagtggtcgcaacaaaag fruI fragment, 116 bp
smu.985 cgccgtttatgtcaggaggtatc ggcattggataagcaggcatagc blgA fragment, 178 bp
smu.987 acgactgcttctcaaacgaatg ctgcttgttcacctgttgatgg wapA fragment, 112 bp

Kanr, Spr and Ermr, for kanamycin, spectinomycin and erythromycin resistance, respectively. Sequences underlined are restriction sites engineered for cloning.